Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910684 · ClinicalTrials.gov registry record · NA
Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT05910684: Completed NA study, sponsored by Qure Healthcare.
NCT05910684 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05910684, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling, and others) of a subset of common patient care indications.
Primary Outcome
Measuring the difference in the quality of care between the control arm and the intervention arm as measured by the number of care decisions made in the second round of chart abstraction. These care decisions might include decisions such as avoidance of invasive diagnostic tests, reductions in unneeded specialist referrals, increased diagnosis and treatment of drug-drug interactions, or care decisions related to costs.
Interventions
- DIAGNOSTIC_TEST Aegis CDM Test and Educational Materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2024-01-30 |
| Phase | NA |
What the finished NCT05910684 record still lists
NCT05910684 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Aegis CDM Test and Educational Materials is the first listed.
NCT05910684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05910684 about?
NCT05910684 is a clinical study titled "Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study". This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling, and others) of a subset of common patient care indications.
What is the current status of trial NCT05910684?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2022-07-19. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT05910684?
The interventions under investigation include: Aegis CDM Test and Educational Materials (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05910684?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05910684's enrollment target sits among peer trials
114 811th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI